11/20
08:03 am
enlv
Form 6-K Enlivex Therapeutics For: Nov 20
High
Report
Form 6-K Enlivex Therapeutics For: Nov 20
11/14
03:30 pm
enlv
Form SC 13G Enlivex Therapeutics Filed by: ARMISTICE CAPITAL, LLC
Low
Report
Form SC 13G Enlivex Therapeutics Filed by: ARMISTICE CAPITAL, LLC
11/14
08:02 am
enlv
Form 6-K Enlivex Therapeutics For: Nov 14
Medium
Report
Form 6-K Enlivex Therapeutics For: Nov 14
11/12
09:26 am
enlv
Form 6-K Enlivex Therapeutics For: Nov 12
Low
Report
Form 6-K Enlivex Therapeutics For: Nov 12
11/8
04:35 pm
enlv
Form 6-K Enlivex Therapeutics For: Nov 08
Low
Report
Form 6-K Enlivex Therapeutics For: Nov 08
10/31
04:06 pm
enlv
Form 6-K Enlivex Therapeutics For: Oct 31
Low
Report
Form 6-K Enlivex Therapeutics For: Oct 31
10/30
08:01 am
enlv
Form 6-K Enlivex Therapeutics For: Oct 30
Medium
Report
Form 6-K Enlivex Therapeutics For: Oct 30
10/15
06:12 am
enlv
Form 6-K/A Enlivex Therapeutics For: Oct 14
Medium
Report
Form 6-K/A Enlivex Therapeutics For: Oct 14
9/26
08:32 am
enlv
Form 6-K Enlivex Therapeutics For: Sep 26
Medium
Report
Form 6-K Enlivex Therapeutics For: Sep 26
9/24
08:33 am
enlv
Form 6-K Enlivex Therapeutics For: Sep 24
Low
Report
Form 6-K Enlivex Therapeutics For: Sep 24
9/11
08:30 am
enlv
Form 6-K Enlivex Therapeutics For: Sep 11
Low
Report
Form 6-K Enlivex Therapeutics For: Sep 11
8/30
04:31 pm
enlv
Form 6-K Enlivex Therapeutics For: Jun 30
Medium
Report
Form 6-K Enlivex Therapeutics For: Jun 30